loader
Please Wait
Applying Filters...

Annual Sales of Tinzaparin sodium reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 29,094Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Fragmin

PharmaCompass

01

Brand Name : Fragmin

Dalteparin

arrow
Discovery on Target
Not Confirmed

02

Brand Name : Fragmin

Dalteparin

arrow
Discovery on Target
Not Confirmed

03

Brand Name : Fragmin

Dalteparin

arrow
Discovery on Target
Not Confirmed

04

Brand Name : Fragmin

Dalteparin

arrow
Discovery on Target
Not Confirmed

Brand Name : Fragmin

arrow
Discovery on Target
Not Confirmed

Dalteparin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 269

2021 Revenue in Millions : 305

Growth (%) : -12

blank

05

Brand Name : Fragmin

Dalteparin

arrow
Discovery on Target
Not Confirmed

Brand Name : Fragmin

arrow
Discovery on Target
Not Confirmed

Dalteparin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 238

2022 Revenue in Millions : 269

Growth (%) : -12

blank